Genpharmasec

Genpharmasec03 May 2024

Trading

₹

-0.04 (-1.82%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Genpharmasec

Genpharmasec

Trading

Genpharmasec03 May 2024

₹

-0.04 (-1.82%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
28-Feb-2019	S	Outcome of Board Meeting held on Thursday, 28th February, 2019 Generic Pharmasec Ltd has informed BSE that the Board of Directors at their meeting held on February 28, 2019 have subject to the approval of shareholders and stock exchange where the shares of the Company are listed, have decided as under:- 1. Sub-division of Equity Shares Equity Shares of the Company having a face value of Rs. 10/- each in the Share Capital of the Company be sub-divided into 10 (ten) Equity Shares having a face value of Re. 1/- each. 2. To convene Extra Ordinary General Meeting (EOGM) of the Company to be held on Saturday the March 30, 2019 and approved the notice pertaining to the same. Trading Members of the Exchange are hereby informed that Generic Pharmasec Limited has fixed Record Date for sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Generic Pharmasec Limited (531592) RECORD DATE 12/04/2019 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into Ten equity shares of Rs. 1/- each. SUB-DIVIDED PAID-UP VALUE Rs.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 11/04/2019 DR- 011/2019-2020 Note:- i. ISIN No. INE861N01028 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 11/04/2019. ii. The new ISIN Number for Rs.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 02.04.2019)	12-Apr-2019
03-Jan-2024	R	1:1 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that GENPHARMASEC LTD has fixed Record date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE GENPHARMASEC LTD (531592) RECORD DATE 09.01.2024 PURPOSE Issue of 1 (One) Equity Shares of Re.1/- each for cash at a premium of Rs.0.75 per Equity Share on Rights Basis for every 1 (One) Equity Share held.* Ex-Right basis from Date & Sett. No. 09/01/2024 DR-692/2023-2024 *As per the Terms of the Payment : - Full amount of the Issue Price of Rs.1.75 per Rights Equity Share shall be payable at the time of Application Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 04.01.2024)	09-Jan-2024	1:1
26-Apr-2024	BC	Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for Appointment of Whole Time Director of the company.	26-Apr-2024
26-Apr-2024	BC	Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for Appointment of Whole Time Director of the company.	26-Apr-2024
21-Mar-2024	BC	Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 inter alia to consider and approve 1. To consider and take on record the resignat	27-Mar-2024
27-Mar-2024	BC	Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, we wish to inform you that Mr. Hardik Makwana is appointed as the Company Secretary and Compliance Officer of the Company w.e.f. 27th March, 2024.	27-Mar-2024
20-Mar-2024	BC	Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 inter alia to consider and approve 1. To Review the performance of Non-Independen	26-Mar-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)1

Ratio1:1

Book Closure

Record Date	Split Date	Purpose
26-Apr-2024	-	Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for Appointment of Whole Time Director of the company.
26-Apr-2024	-	Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for Appointment of Whole Time Director of the company.
27-Mar-2024	-	Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 inter alia to consider and approve 1. To consider and take on record the resignat
27-Mar-2024	-	Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, we wish to inform you that Mr. Hardik Makwana is appointed as the Company Secretary and Compliance Officer of the Company w.e.f. 27th March, 2024.
26-Mar-2024	-	Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 inter alia to consider and approve 1. To Review the performance of Non-Independen

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Genpharmasec Ltd ₹2.16(-0.04/-1.82%)	2.16	-0.04	119.60	9.09	108.00	1.85
Computer Point Ltd ₹5.09(+0.12/2.41%)	5.09	+0.12	15.27	116.60	0.00	0.46
Ambalal Sarabhai Enterprises Ltd ₹45.47(-0.68/-1.47%)	45.47	-0.68	348.45	102.27	0.00	9.57
Novartis India Ltd ₹1,057.25(+18.10/1.74%)	1,057.25	+18.10	2,610.43	77.90	27.33	3.72
Aegis Logistics Ltd ₹629.30(-14.10/-2.19%)	629.30	-14.10	22,088.43	60.91	50.06	9.95
Modella Woollens Ltd ₹74.01(+2.01/2.79%)	74.01	+2.01	6.73	0.76	0.00	-73.29

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	6.38	7.86	5.96	6.22	6.41	6.02
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	6.38	7.86	5.96	6.22	6.41	6.02
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.14	0.15	0.11	0.06	0.02	0.00
Total Income	6.53	8.01	6.08	6.27	6.42	6.02
Total Expenditure	6.37	7.90	5.94	6.01	6.18	5.95
PBIDT	0.16	0.11	0.13	0.26	0.24	0.07
Interest	0.12	0.07	0.06	0.06	0.00	0.00
PBDT	0.03	0.05	0.07	0.21	0.24	0.07
Depreciation	0.00	0.00	0.01	0.01	0.01	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.03	0.04	0.04	-0.84	0.00	0.00
Reported Profit After Tax	0.06	0.01	0.03	1.05	0.24	0.06
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.06	0.01	0.03	1.05	0.24	0.06

EPS (Unit Curr.)	0.00	0.00	0.00	0.04	0.01	0.00
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.02	0.01	0.00
Calculated EPS (Unit Curr.)	0.00	0.00	0.00	0.38	0.09	0.00
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.23	0.05	0.00
Calculated EPS (Ann.) (Unit Curr.)	0.01	0.00	0.00	1.51	0.34	0.01
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.01	0.00	0.00	0.91	0.20	0.01
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	27.69	27.69	27.69	27.69	27.69	27.69
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	10.00	10.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	2.51	1.40	2.18	4.18	3.74	1.16
PBDTM(%)	0.47	0.64	1.17	3.38	3.74	1.16
PATM(%)	0.94	0.13	0.50	16.88	3.74	1.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	27.69	27.69	27.69	21.69	21.69	0.33
Reserves Total	-12.36	-12.32	-7.02	-4.15	-1.57	-1.19
Equity Share Warrants	0.00	0.00	0.00	1.50	1.50	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	15.33	15.37	20.67	19.04	21.62	-0.86
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	3.08	0.00	0.00	0.00	0.00	0.99
Total Debt	3.08	0.00	0.00	0.00	0.00	0.99
Total Liabilities	18.41	15.37	20.67	19.04	21.62	0.13
APPLICATION OF FUNDS :
Gross Block	0.15	0.14	0.07	0.05	0.01	0.01
Less : Accumulated Depreciation	0.05	0.03	0.02	0.01	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.10	0.11	0.05	0.04	0.01	0.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.95	2.45	7.81	5.76	7.53	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	9.68	9.89	7.68	3.46	0.00	0.00
Sundry Debtors	5.71	6.45	7.52	7.03	0.04	0.00
Cash and Bank	1.99	1.61	3.53	2.58	5.20	0.16
Loans and Advances	0.59	1.15	0.38	0.53	0.96	0.00
Total Current Assets	17.97	19.10	19.12	13.60	6.20	0.16
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.46	6.28	7.16	5.58	0.02	0.02
Provisions	0.00	0.00	0.00	0.15	0.00	0.01
Total Current Liabilities	1.46	6.28	7.16	5.72	0.02	0.03
Net Current Assets	16.51	12.82	11.96	7.88	6.18	0.12
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.85	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.85	0.00	0.00	0.00	0.00	0.00
Total Assets	18.41	15.37	19.82	13.69	13.71	0.12
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.61	3.53	2.58	5.20	0.16
Net Cash from Operating Activities	-3.23	-2.34	-2.13	1.39	-6.40
Net Cash Used In Investing Activities	0.54	0.42	-1.41	-4.01	-10.42
Net Cash Used In Financing Activities	3.08	0.00	4.50	0.00	21.87
Net Inc./Dec In Cash And Cash Equivalents	0.39	-1.93	0.96	-2.62	5.04
Cash And Cash Equivalents At End Of The Year	1.99	1.61	3.53	2.58	5.20

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

29.98%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

70.02%

**Promoter pledged shareholding 29.98%

About Genpharmasec Ltd

Genpharmasec Ltd is in the Trading sector, having a market capitalization of Rs. 119.6 crores. It has reported a sales of Rs. 6.38 crores and a net profit of Rs. 0.06 crores for the quarter ended December 2018. The company management includes , Ulhas Narayan Deosthale,Rajesh Sadhwani,Sneha Sadhwani,Siddhesh Shankar Shende,Mayur Bharatbhai Bhatt,Sachin Aphandkar,Heta Shah (Genpharmasec Ltd) among others.

Chairman

Registered office

Office 104 & 105 1st Flr,Gundecha Indl Kandivali (East),Mumbai,Maharashtra,400101

FAX :

Background

Incorporation Year1992

Face Value₹1

Market Lot1

How to buy Genpharmasec shares on nse?

To buy Genpharmasec shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Genpharmasec share price today?

The Genpharmasec shares price on nse is Rs.2.16 today.

What is the market cap of Genpharmasec shares on BSE ?

The company has a market capitalization of Rs.119.60Cr

What is the PE & PB ratio of Genpharmasec shares ?

PE is 108 and PB is 1.85

What is the 52 Week High and Low of Genpharmasec shares?

Genpharmasec stock price high: Rs.7.31 Genpharmasec stock price low: Rs.1.69